Modern Vascular Revenue and Competitors
Estimated Revenue & Valuation
- Modern Vascular's estimated annual revenue is currently $46.6M per year.
- Modern Vascular's estimated revenue per employee is $382,205
Employee Data
- Modern Vascular has 122 Employees.
- Modern Vascular grew their employee count by 21% last year.
Modern Vascular Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.9M | 25 | -4% | N/A | N/A |
#2 | $8M | 29 | -12% | N/A | N/A |
#3 | $8.6M | 31 | 19% | N/A | N/A |
#4 | $9.9M | 40 | 0% | N/A | N/A |
#5 | $50.5M | 132 | 7% | N/A | N/A |
#6 | $5.3M | 22 | -8% | N/A | N/A |
#7 | $20.8M | 60 | 7% | N/A | N/A |
#8 | $10.6M | 38 | 0% | N/A | N/A |
#9 | $8.4M | 30 | 7% | N/A | N/A |
#10 | $4.2M | 17 | -6% | N/A | N/A |
What Is Modern Vascular?
Modern Vascular facilities are a group of affiliated outpatient clinics providing minimally invasive endovascular procedures to treat PAD ? Peripheral Artery Disease. Our mission is to advance regular screening, early diagnosis, and successful treatment of PAD. Our name defines our approach, techniques, and commitment to saving toes, feet, legs, and lives.
keywords:N/A
N/A
Total Funding
122
Number of Employees
$46.6M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Modern Vascular News
Endovascular procedures for the treatment of PAD have become a crucial cornerstone of modern vascular medicine, and the first line...
Dr. Steve Berkowitz, Chief Medical Officer with Modern Vascular, shares what Peripheral Artery Disease is & how patients can get help.
Modern Vascular, a nationally renowned clinic for those dealing with peripheral artery disease and other vascular issues, has opened its...
Other Companies in Mesa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.7M | 123 | 17% | N/A |
#2 | $29.1M | 126 | 22% | N/A |
#3 | $34.7M | 126 | 10% | N/A |
#4 | $30.9M | 129 | 19% | N/A |
#5 | $19.3M | 130 | -13% | N/A |